Novel marker vaccines against classical swine fever

Hulst, 1993, Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera, J Virol, 67, 5435, 10.1128/JVI.67.9.5435-5442.1993 Luetticken, 1998, The relevance of CSF marker vaccines for field use van Oirschot, 1999, Diva vaccines that reduce virus transmission, J Biotechnol, 73, 195, 10.1016/S0168-1656(99)00121-2 van Rijn, 1996, Classical swine fewer virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge, J Gen Virol, 77, 2737, 10.1099/0022-1317-77-11-2737 Bouma, 1999, Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus, Vet Microbiol, 66, 101, 10.1016/S0378-1135(99)00003-6 Uttenthal, 2001, Classical swine fever (CSF) marker vaccine Trial I. Challenge study in weaner pigs, Vet Microbiol, 83, 85, 10.1016/S0378-1135(01)00409-6 Depner, 2001, Classical swine fever (CSF) marker vaccine Trial II: Challenge study in pregnant sows, Vet Microbiol, 83, 107, 10.1016/S0378-1135(01)00410-2 Meyers, 1996, Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs, J Virol, 70, 8606, 10.1128/JVI.70.12.8606-8613.1996 Moormann, 1996, Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus, J Virol, 70, 763, 10.1128/JVI.70.2.763-770.1996 Ruggli, 1996, Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J Virol, 70, 3478, 10.1128/JVI.70.6.3478-3487.1996 Vassilev, 1997, Authentic and chimeric full-length genomic cDNA clones of bovine viral diarrhea virus that yield infectious transcrips, J Virol, 71, 471, 10.1128/JVI.71.1.471-478.1997 van Rijn, 1999, An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV), Vaccine, 17, 433, 10.1016/S0264-410X(98)00215-1 de Smit, 2000, Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics, Vaccine, 18, 2351, 10.1016/S0264-410X(00)00027-X van Gennip, 2000, Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response, Vaccine, 19, 447, 10.1016/S0264-410X(00)00198-5 Widjojoatmodjo, 2000, Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines, J Virol, 74, 2973, 10.1128/JVI.74.7.2973-2980.2000 de Smit, 2001, Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination, Vet Microbiol, 78, 307, 10.1016/S0378-1135(00)00306-0 Floegel-Niesmann, 2001, Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs, Vet Microbiol, 83, 121, 10.1016/S0378-1135(01)00411-4 Dong, 2002, Candidate peptide vaccine induced protection against classical swine fever virus, Vaccine, 21, 167, 10.1016/S0264-410X(02)00466-8 Dong, 2005, Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker, Vaccine, 23, 3630, 10.1016/j.vaccine.2005.02.008 Dong, 2006, Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2, Vaccine, 24, 426, 10.1016/j.vaccine.2005.08.002 Dong, 2006, Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2, Vaccine, 24, 1906, 10.1016/j.vaccine.2005.10.039 Dong, 2006, Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus, Vaccine, 24, 4029, 10.1016/j.vaccine.2006.01.003 Liu, 2006, The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2, J Virol Methods, 134, 125, 10.1016/j.jviromet.2005.12.008 Andrew, 2000, Coupar BE Protection of pigs against classical swine fever with DNA-delivered gp55, Vaccine, 18, 1932, 10.1016/S0264-410X(99)00445-4 Harpin, 1997, Immune response to vaccination with DNA encoding the bovine viral diarrhoea virus major glycoprotein gp53 (E2), FEMS Microbiol Lett, 146, 229, 10.1111/j.1574-6968.1997.tb10198.x Yu, 2001, DNA-mediated protection against classical swine fever virus, Vaccine, 19, 1520, 10.1016/S0264-410X(00)00334-0 Nobiron, 2003, DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge, Vaccine, 21, 2082, 10.1016/S0264-410X(02)00745-4 Ganges, 2005, A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge, Vaccine, 23, 3741, 10.1016/j.vaccine.2005.01.153 Liang, 2005, Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses, Vaccine, 23, 5252, 10.1016/j.vaccine.2005.06.025 Wienhold, 2005, Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination, Vet Res, 36, 571, 10.1051/vetres:2005019 Andrew, 2006, Porcine interleukin-3 enhances DNA vaccination against classical swine fever, Vaccine, 24, 3241, 10.1016/j.vaccine.2006.01.023 König, 1995, Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins, J Virol, 69, 6479, 10.1128/JVI.69.10.6479-6486.1995 van Zijl, 1991, Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera, J Virol, 65, 2761, 10.1128/JVI.65.5.2761-2765.1991 Hooft van Iddekinge, 1996, Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection, Vaccine, 14, 6, 10.1016/0264-410X(95)00165-W Mulder, 1994, Virulence and pathogenesis of non-virulent and virulent strains of pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus, J Gen Virol, 75, 117, 10.1099/0022-1317-75-1-117 Peeters, 1997, Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever, J Gen Virol, 78, 3311, 10.1099/0022-1317-78-12-3311 Hammond, 2000, Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever, Vaccine, 18, 1040, 10.1016/S0264-410X(99)00347-3 Hammond, 2001, Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene, Arch Virol, 146, 1787, 10.1007/s007050170064 Hammond, 2003, Protection of pigs against ’in contact’ challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus, Virus Res, 97, 151, 10.1016/j.virusres.2003.08.003 Hammond, 2005, Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics, Vet J, 169, 17, 10.1016/j.tvjl.2003.09.007 Hahn, 2001, Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein, J Virol Methods, 93, 49, 10.1016/S0166-0934(00)00296-2 Voigt H. Rekombinante Parapockenvakzine gegen klassische Schweinepest: Vergleichende Charakterisierung der Immunreaktionen im Schwein. Inaugural-Dissertation LMU München; 2005. Reimann, 2004, An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus, Virology, 322, 143, 10.1016/j.virol.2004.01.028 de Smit, 2001, Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination, Vet Microbiol, 78, 307, 10.1016/S0378-1135(00)00306-0 van Gennip, 2002, Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV, Vaccine, 20, 1544, 10.1016/S0264-410X(01)00497-2 Maurer, 2005, Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV, Vaccine, 23, 3318, 10.1016/j.vaccine.2005.01.076 Frey, 2006, Classical swine fewer virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application, Vet Res, 37, 655, 10.1051/vetres:2006028 Hoffmann, 2006, A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses, J Virol Methods, 136, 200, 10.1016/j.jviromet.2006.05.020 Hoffmann, 2005, Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever, J Virol Methods, 130, 36, 10.1016/j.jviromet.2005.05.030 Depner K, Hoffmann B, Beer M. Does real-time RT-PCR for CSF mark the beginning of a paradigm shift in the control of CSF? In: Vennier P, Espeseth D, editors, New diagnostic technology: applications in animal health and biologics controls, vol. 126. Dev Biol (Basel). Basel, Karger; 2006. p. 115–6.